Multivisceral Transplant

Introduction

A multivisceral transplant is one of the most complex operations in modern medicine. It replaces several abdominal organs at the same time — usually the small intestine, liver, stomach, and pancreas, sometimes together with the duodenum and a portion of the colon. It is offered to a small number of patients each year who have severe failure of more than one digestive organ and who cannot be safely managed by any other treatment.

If you or a family member is being considered for this operation, you are likely facing a long journey that began with intestinal failure, liver disease, or both. You may already have spent months or years on intravenous nutrition (also called parenteral nutrition or TPN), and you may have been told that this support is no longer working safely. Hearing that a multi-organ transplant is the next step can feel overwhelming.

This article explains what a multivisceral transplant involves, who it is offered to, what alternatives doctors consider first, how the surgery is performed, what recovery looks like in hospital and at home, and what life is like in the months and years afterwards. It is written for patients and families who are now planning this phase of care, not for people researching abdominal pain for the first time.

What Is a Multivisceral Transplant?

A multivisceral transplant is the surgical replacement of several abdominal organs from a single deceased donor. The exact combination of organs depends on the patient’s disease, but it usually includes the small intestine and at least two other organs that share the same blood supply through the coeliac axis and the superior mesenteric artery — the main arteries that feed the upper abdomen.

Three related operations are often discussed together, and it helps to know how they differ:

• Isolated intestinal transplant. Only the small intestine is replaced. This is offered when the liver is still healthy.
• Combined liver and intestine transplant. The small intestine is replaced together with the liver, but the stomach and pancreas are left in place.
• Multivisceral transplant. The small intestine, liver, stomach, and pancreas are replaced as a single block, sometimes with the duodenum and part of the colon. A “modified multivisceral transplant” replaces the stomach, pancreas, and intestine but keeps the patient’s own liver.

The team chooses among these options based on which organs are failing, the condition of the abdomen, the patient’s age and overall health, and the technical anatomy of the disease. Because the organs in a multivisceral graft share a single arterial supply, they can be transplanted as one connected unit, which has surgical and immunological advantages in selected patients.

Multivisceral transplantation is a relatively young field. Only a small number of transplant centres around the world perform it, and even fewer perform it in significant numbers. Outcomes have improved substantially over the last two decades, but it remains a treatment reserved for patients who have no safer alternative.

Why Is a Multivisceral Transplant Performed?

Multivisceral transplant is considered when several abdominal organs have failed together, and when the patient’s life cannot be sustained by other means. The most common situations include:

• Intestinal failure with liver failure caused by long-term parenteral nutrition. When the small intestine cannot absorb enough nutrition, patients depend on intravenous feeding through a central line. Over months and years, this can damage the liver, leading to a condition called intestinal failure–associated liver disease (IFALD). When both organs are failing, replacing only the intestine is not enough.
• Extensive abdominal tumours that cannot be removed otherwise. Slow-growing tumours such as desmoid tumours, certain neuroendocrine tumours, and some sarcomas can wrap around the major abdominal blood vessels. In carefully selected cases, removing all the involved organs and replacing them with a transplant is the only way to remove the disease completely.
• Diffuse vascular thrombosis of the abdominal vessels. Conditions that cause widespread clotting in the arteries and veins of the abdomen can damage multiple organs at once. When the damage is irreversible, transplantation may be the only option.
• Extensive trauma or catastrophic intra-abdominal events that destroy several organs together.
• Complex motility disorders such as severe chronic intestinal pseudo-obstruction, when these affect the stomach as well as the intestine.

In children, the most common reasons differ from adults and are described in a separate section below.

Who Is a Candidate?

Multivisceral transplantation is offered after a detailed evaluation by a transplant team that usually includes a transplant surgeon, a gastroenterologist or hepatologist, a transplant anaesthetist, a nutrition specialist, a transplant pharmacist, a psychologist or psychiatrist, a social worker, and a transplant coordinator.

The team looks at several broad questions:

• Is there a clear medical need? The patient’s organs must be failing in a way that cannot be reversed, and other treatments must have been tried or considered. For patients on parenteral nutrition, this usually means progressive liver damage, repeated central line infections, loss of venous access for the line, or recurrent episodes of dehydration that cannot be controlled.
• Is the patient strong enough to undergo the operation? Multivisceral transplant is one of the longest and most physiologically demanding operations in surgery. The heart, lungs, and kidneys are assessed carefully. Severe damage to any of these organs may make the surgery unsafe.
• Is there active, uncontrolled infection or cancer? Active infection in the bloodstream, untreated cancer outside the transplant field, and certain other conditions are usually reasons not to proceed at that time.
• Can the patient and family commit to lifelong follow-up? Transplant recipients need to take immunosuppressant medications every day, attend regular blood tests and clinic visits, and recognise problems early. This commitment is part of the assessment.

The final decision is made by the transplant team after reviewing all of this information together. If a patient is accepted, they are placed on a national waiting list and may wait weeks, months, or longer for a suitable donor.

Alternatives to Multivisceral Transplant

Because multivisceral transplant is so complex, doctors and transplant teams usually exhaust other treatments first. The alternatives depend on the underlying problem.

Intestinal Rehabilitation and Parenteral Nutrition

For patients with short bowel syndrome or intestinal failure, the first approach is intestinal rehabilitation. This combines specialised nutrition, medication to slow transit, and careful management of intravenous feeding. With expert care, many patients can stay on parenteral nutrition for years, and some recover enough intestinal function to come off it. Newer medications that promote intestinal adaptation, such as glucagon-like peptide-2 analogues, have improved outcomes for some patients.

Autologous Bowel Reconstructive Surgery

For some patients, particularly children with short bowel syndrome, surgeries on the patient’s own intestine can lengthen the bowel and improve absorption. Procedures such as the serial transverse enteroplasty (STEP) and the longitudinal intestinal lengthening and tailoring (LILT, or Bianchi procedure) can sometimes reduce or eliminate the need for parenteral nutrition.

Liver-Only or Intestine-Only Transplant

If only one organ has failed irreversibly, replacing just that organ may be safer. Isolated intestinal transplant is offered to patients whose liver is still healthy. Combined liver-intestine transplant is offered when the liver has failed but the stomach and pancreas are still functioning well. Multivisceral transplant is reserved for cases where these narrower operations would not solve the problem.

Palliative Care

For some patients, the burden of a multivisceral transplant outweighs the likely benefit. In these situations, the transplant team may recommend continuing supportive care rather than proceeding to surgery. This is a difficult conversation but an honest one, and good palliative care can support quality of life when transplant is not the right choice.

Types of Multivisceral Transplant

The transplant team plans the operation around the patient’s specific anatomy and disease. The main variations are:

Full Multivisceral Transplant

The stomach, duodenum, pancreas, small intestine, and liver are transplanted together as one block. This is used when all of these organs are diseased or when the disease affects the blood vessels that feed them.

Modified Multivisceral Transplant

The stomach, duodenum, pancreas, and small intestine are transplanted, but the patient’s own liver is preserved. This is used when the liver is still healthy and can be safely separated from the diseased organs.

Multivisceral Transplant Including Colon

In selected cases, a portion of the donor colon is included to improve fluid absorption after surgery. This can reduce the volume of fluid the patient loses through stoma output or stool.

Preparing for a Multivisceral Transplant

Once a patient is listed for transplant, preparation continues during the wait. The goals are to keep the patient as strong and stable as possible and to be ready to move quickly when a donor organ becomes available.

Medical Optimisation

Nutrition is reviewed and adjusted regularly. Infections, particularly those related to central venous catheters, are treated promptly. Vaccinations are updated where possible, because some vaccines cannot be safely given after transplant. Dental care is completed before surgery to reduce the risk of infection later.

Physical Conditioning

Maintaining muscle strength matters. Even simple daily exercise, breathing exercises, and physiotherapy can make a measurable difference to how a patient recovers. The transplant team often involves a physiotherapist in the pre-transplant phase.

Psychological and Social Preparation

A transplant changes life in significant ways. Psychologists, social workers, and transplant coordinators help patients and families understand what to expect, plan for the hospital stay, arrange caregiver support, and prepare for the long follow-up period afterwards.

The Call

When a donor organ becomes available and is matched to the patient, the team will call the patient to come to the hospital. The patient must not eat or drink from that moment. On arrival, blood tests, imaging, and final checks are performed quickly to confirm fitness for surgery. If anything has changed — for example, a new infection — the team may decide to wait for another donor.

What Happens During a Multivisceral Transplant

Removing the Diseased Organs

The surgeon opens the abdomen and carefully removes the failing organs. This is often the most difficult part of the operation, especially if the patient has had previous abdominal surgery, scarring, or tumours wrapped around major blood vessels. Bleeding can be significant, and the anaesthetic team carefully manages blood pressure, clotting, and temperature throughout.

Placing the New Organs

The donor organs are placed into the abdomen as a single block. The main artery of the graft is connected to the recipient’s aorta, and the venous drainage is connected to the recipient’s vena cava or portal vein system. Once blood flow is restored, the surgeon connects the digestive tract — usually joining the donor stomach or oesophagus to the recipient’s oesophagus or remaining upper digestive tract at one end, and the donor intestine to the recipient’s colon or rectum at the other end.

The Stoma

In almost all multivisceral transplants, the surgeon brings a small portion of the new intestine out through the skin of the abdomen as a stoma (an ileostomy). This allows the team to take small biopsies of the new intestine in the weeks after surgery to look for early signs of rejection. The stoma is usually closed in a smaller operation several months later, once the team is confident that the transplant is stable.

Closing the Abdomen

Closing the abdomen can be challenging because the transplanted organs may not fit easily inside, particularly if the patient’s abdominal cavity has shrunk during a long illness. Surgeons use a variety of techniques to close the wound safely, and in some cases temporary mesh or staged closure is needed.

Recovery and Healing

Intensive Care Unit

After surgery, the patient is taken to the intensive care unit. A breathing tube, multiple drips, drains, and monitoring lines are in place. The first 24 to 72 hours focus on stabilising blood pressure, supporting breathing, controlling pain, and watching for early bleeding or graft problems. Most patients stay in intensive care for one to three weeks, depending on their condition.

The Transplant Ward

Once stable, the patient moves to a specialised transplant ward. Here the team gradually reduces intravenous support and starts feeding through the new intestine. Feeding usually begins through a tube directly into the small intestine, and oral eating is introduced slowly as the gut wakes up.

Routine biopsies of the new intestine are taken through the stoma in the first weeks. These are checked under the microscope to look for rejection, which is much more common in intestinal transplants than in other organ transplants. Immunosuppressant medications are adjusted carefully based on these results.

Most patients stay in hospital for six to eight weeks after a multivisceral transplant, although this varies widely. Complications such as infections, rejection episodes, or wound problems can extend the stay.

Discharge and Early Months at Home

After discharge, follow-up is intensive. In the first three months, clinic visits and blood tests may happen several times a week. The team monitors immunosuppressant drug levels, kidney function, infection markers, and signs of rejection. Patients usually continue to need close support from a caregiver during this period.

By six months, most patients who recover well are eating most of their nutrition by mouth, the stoma is being prepared for closure, and energy is starting to return. Full recovery, in the sense of feeling reasonably normal again, generally takes a year or more.

Risks and Complications

Multivisceral transplant carries significant risks. It is important to understand these honestly when deciding whether to proceed.

Early Surgical Complications

• Bleeding. The surgery involves major blood vessels and a long operating time. Bleeding may require return to the operating theatre.
• Vascular complications. Clotting or narrowing of the artery or vein supplying the new organs can threaten the graft and may require urgent intervention.
• Anastomotic leak. A leak from one of the surgical connections in the digestive tract can cause infection inside the abdomen.
• Wound problems. Difficulty closing the abdomen can lead to hernias or wound infections.

Rejection

The intestine is rich in immune tissue, which makes it more prone to rejection than organs such as the kidney or liver. Acute rejection is common in the first months after a multivisceral transplant and is usually treated by increasing immunosuppressant medication. Chronic rejection can develop over years and is harder to treat. Routine biopsies are the main way of catching rejection early.

Infection

Immunosuppressant medications, which prevent rejection, also lower the body’s ability to fight infection. Bacterial, viral, and fungal infections are common after transplant. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are watched particularly closely because they can cause serious illness in transplant recipients.

Graft-Versus-Host Disease

Because the donor organs carry donor immune cells, those cells can sometimes attack the recipient’s body. This condition, called graft-versus-host disease, is rare but serious and can affect the skin, liver, and other tissues.

Post-Transplant Lymphoproliferative Disorder (PTLD)

Long-term immunosuppression slightly increases the risk of certain cancers, particularly a condition called PTLD, which is related to Epstein-Barr virus. PTLD is more common after intestinal and multivisceral transplant than after most other transplants. It can often be treated by reducing immunosuppression and giving specific therapies.

Kidney and Other Organ Effects

Some immunosuppressant medications, particularly tacrolimus, can damage the kidneys over time. The team monitors kidney function carefully and adjusts medications to balance the risk of rejection against the risk of kidney injury.

Mortality

Multivisceral transplant carries a higher early mortality than most other organ transplants. Survival has improved substantially over the past two decades with better surgical technique, immunosuppression, and infection prevention. Modern published series describe roughly half to two-thirds of recipients alive at five years, though numbers vary widely between centres and depend heavily on the patient’s condition at the time of surgery. Your transplant team can give you a more individual estimate based on your situation.

Life After a Multivisceral Transplant

Patients who recover well from a multivisceral transplant often describe a major improvement in quality of life. Being free of parenteral nutrition, being able to eat and drink normally, and not depending on a central line can transform daily living. At the same time, transplant introduces new lifelong responsibilities.

Immunosuppression for Life

Every multivisceral transplant recipient takes immunosuppressant medications every day for the rest of their life. The exact combination varies, but typically includes a calcineurin inhibitor (most commonly tacrolimus), often together with other agents in the early period. Doses are adjusted based on blood levels and how the patient is doing. Missing doses, even briefly, can trigger rejection.

Diet and Nutrition

Eating returns gradually. Many patients start with small, frequent meals and slowly expand the diet as the new intestine adapts. A transplant dietitian guides this process. Most patients are eventually able to eat a varied diet, though some find that certain foods cause more bowel symptoms than others. Vitamin and mineral levels are checked regularly, because absorption may be slightly different than in a person without transplant.

Stoma Care and Closure

While the stoma is in place, a stoma nurse helps patients learn to manage it, change the bag, and recognise problems. When the team is confident that the transplant is stable — usually several months after surgery — the stoma can be closed in a smaller operation, allowing bowel movements to pass normally.

Infection Awareness

Recipients learn to recognise warning signs — fever, chills, new abdominal pain, changes in stoma output, breathing problems, or unusual fatigue — and to contact the transplant team promptly. Routine vaccinations are kept up to date, although live vaccines are usually avoided. Care is needed around crowded places, contact with sick people, and certain foods that carry infection risk.

Follow-Up Schedule

Follow-up is most intense in the first year. Over time, if all is going well, visits become less frequent, but they continue for life. Routine blood tests, imaging, and occasional endoscopic biopsies remain part of long-term care.

Return to Work, School, and Activity

Many recipients return to work or school within six to twelve months, depending on the kind of work they do and how their recovery has gone. Physical activity is encouraged once healing is complete. Travel is possible but requires planning, including ensuring access to medications and a safe medical environment.

Pregnancy and Family Planning

Pregnancy is possible for some recipients but needs careful planning with both the transplant team and an obstetrician experienced in transplant recipients. Some immunosuppressant medications need to be changed before pregnancy.

Emotional Health

The psychological impact of a transplant is significant. Many recipients experience a mix of gratitude, anxiety, grief for the donor, and pressure to “make the most” of the gift. Counselling, peer support groups, and ongoing involvement with transplant psychologists are valuable parts of long-term care.

Multivisceral Transplant in Children

Children make up a significant share of multivisceral transplant recipients worldwide, and the reasons for transplant in children differ from those in adults.

Common Reasons in Children

• Short bowel syndrome from conditions present at or near birth, such as gastroschisis, intestinal atresia, midgut volvulus, or necrotising enterocolitis.
• Congenital enteropathies such as microvillus inclusion disease and tufting enteropathy, which prevent normal intestinal absorption.
• Severe motility disorders such as total intestinal aganglionosis (an extensive form of Hirschsprung disease) or chronic intestinal pseudo-obstruction.
• Intestinal failure with liver failure from long-term parenteral nutrition.

Special Considerations

Donor size matching is more difficult in children, particularly small infants, because the new organs must physically fit. Specialised paediatric transplant centres use techniques such as reduced-size grafts to address this. Children who receive multivisceral transplants often need additional support for growth, development, and schooling during recovery.

Outcomes

Long-term outcomes in children have improved significantly. Many children come off parenteral nutrition completely, return to school, and grow well, although they need lifelong follow-up. Families work closely with paediatric transplant teams, dietitians, schools, and psychologists to support the child through recovery and into adult life. Transition to adult transplant services is planned carefully in the teenage years.

Frequently Asked Questions

How long does the surgery take?

A multivisceral transplant typically takes between eight and fifteen hours, depending on the patient’s anatomy, previous surgeries, and the exact combination of organs being transplanted.

How long will I be in hospital?

Most patients spend one to three weeks in intensive care and a total of six to eight weeks in hospital, although complications can lengthen the stay considerably. Discharge happens when feeding is established, immunosuppression is stable, and the patient is well enough to be managed as an outpatient.

Will I be able to eat normally again?

Most recipients who recover well are eventually able to eat a varied oral diet. Eating returns gradually, often starting with tube feeds into the new intestine and progressing to small frequent meals and then a normal diet over months. Some recipients find that certain foods cause more bowel symptoms than others.

Will I need parenteral nutrition after the transplant?

The main goal of a multivisceral transplant in most patients is to come off parenteral nutrition. Many recipients achieve this within months of surgery, although a short period of supplementary intravenous support is common in the early recovery period.

How long do I need to take immunosuppressant medications?

Immunosuppressant medications continue for life. The doses are usually highest in the first months and are reduced gradually as the transplant stabilises, but they are never stopped completely without risking rejection.

What are the chances the transplant will be rejected?

Some degree of rejection in the first year after a multivisceral transplant is common because the intestine is rich in immune tissue. Most rejection episodes are caught early through routine biopsies and treated successfully by adjusting medications. Chronic rejection, which develops slowly over years, is less common but more difficult to manage.

Can the stoma be closed?

In most patients, the stoma is closed several months after the transplant once the team is confident the new intestine is stable. After closure, bowel movements pass through the natural route. A small number of patients keep the stoma long-term if there are technical or medical reasons.

Can I travel after the transplant?

Yes, with planning. Recipients are usually advised to avoid long-distance travel in the first months after surgery. Once stable, travel is possible but requires careful preparation, including carrying enough medication, knowing how to access medical care at the destination, and avoiding places with high infection risk during periods of strong immunosuppression.

How will I know if something is wrong?

Warning signs include fever, new abdominal pain, changes in stoma output (much more or much less than usual), vomiting, breathing problems, jaundice, or unusual fatigue. If any of these happen, you should contact the transplant team promptly rather than waiting.

Can I have children after a multivisceral transplant?

Pregnancy is possible in some recipients but needs to be planned carefully with the transplant team and an obstetrician experienced in transplant care. Some medications need to be changed before pregnancy, and pregnancy is usually delayed until the transplant is stable, often for at least one to two years after surgery.

Conclusion

A multivisceral transplant is one of the most demanding operations in surgery, offered only to patients with severe combined organ failure who have no safer alternative. For those who are good candidates, it can lift the burden of parenteral nutrition, restore the ability to eat, and offer a meaningful return to daily life — though it also brings lifelong medications, regular monitoring, and a real risk of complications.

If you or a family member is considering this operation, the most important step is detailed discussion with a transplant team experienced in intestinal and multivisceral transplantation. They can review your specific situation, weigh the alternatives, explain the realistic risks and benefits, and help you and your family plan the road ahead with clear eyes.